;

Statistics for Array BioPharma (id:6416 ARRY)

Valuation metrics

Market cap

858.48M

Enterprise value

1.56B

Trailing P/E (ttm)

61.85

Forward P/E

6.42

PEG ratio

6.42

Price/Sales (ttm)

3.00

Price/Book (mrq)

13.33

Enterprise Value/Revenue

1.59

Enterprise Value/EBITDA

10.94

Overview

Shares outstanding

151.94M

Float

138.06M

Shares short

21.91M

% Held by insiders

5.00%

% Held by institutions

1.26%

Average volume (10 days)

6.22M

Average volume (90 days)

Price summary

52-Week low

5.15

52-Week high

17.76

52-Week change

-208.53%

Beta

1.61

50-Day moving average

6.41

200-Day moving average

9.51

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31, 2023

Most recent quarter (mrq)

September 30, 2024

Profitability

Profit margin

-9.59%

Operating margin

12.66%

Operational effectiveness

Return on assets

3.89%

Return on equity

-17.54%

Income statement

Revenue (ttm)

6.48

Revenue per share (ttm)

6.48

Quarterly revenue growth (yoy)

3.00

Gross profit (ttm)

415.55M

EBITDA

173.89M

Net income to common (ttm)

-148,812,992.00

Diluted EPS (ttm)

3.00

Quarterly earnings growth (yoy)

-33.97%

Balance sheet

Total cash (mrq)

332.37M

Total cash per share (mrq)

2.19

Total debt (mrq)

693.26M

Total Debt/Equity (mrq)

151.67

Current ratio (mrq)

240.70%

Book value per share (mrq)

3.00

Cash flow

Cash flow statement

190.38M

Levered free cash flow (LFCF)

211.89M